Blog
RSS FeedPosted by Michael Wonder on 15 Jan 2020
Reform at the FDA—in need of reform
14 January 2020 - On 23 December 2016, the US FDA announced the approval of nusinersen, the first drug for the ...
Posted by Michael Wonder on 15 Jan 2020
TLV has decided to reconsider the subsidy for Xeljanz
14 January 2020 - When TLV decided that Xeljanz should be included in the high-cost protection, this was justified by the ...
Posted by Michael Wonder on 09 Jan 2020
Human medicines: highlights of 2019
9 January 2020 - EMA has published a review of its key recommendations in 2019 on the authorisation and safety ...
Posted by Michael Wonder on 08 Jan 2020
PBAC – 2019 in review
8 January 2020 - The PBAC considered 188 submissions in 2019. ...
Posted by Michael Wonder on 06 Jan 2020
Novel drug approvals for 2019
2 January 2020 - How many of the 'novel' drugs approved by the FDA in 2019 are actually new medicines in ...
Posted by Michael Wonder on 03 Dec 2019
The use of risk-sharing contracts in health care: theoretical and empirical assessments
3 December 2019 - The aim of this review is to provide a summary of the literature on risk-sharing agreements, including ...
Posted by Michael Wonder on 01 Dec 2019
The ‘Top 10’ challenges for health technology assessment: INAHTA viewpoint
28 November 2019 - The International Network of Agencies for Health Technology Assessment (INAHTA) spans the globe as a network of ...
Posted by Michael Wonder on 18 Nov 2019
Biostatistics: a fundamental discipline at the core of modern health data science
28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...
Posted by Michael Wonder on 09 Oct 2019
High health care costs suggest review is needed: report
8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...
Posted by Michael Wonder on 08 Oct 2019
ICER identifies costliest US drug-price hikes that are not supported by new clinical evidence
8 October 2019 - In 2017 and 2018, out of nine identified drugs that had substantial price increases on top of ...
Posted by Michael Wonder on 03 Sep 2019
Bad diagnosis: health care system muddled, lacking leadership major report finds
3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...
Posted by Michael Wonder on 28 Aug 2019
An international perspective on the paradoxes of US health care
28 August 2019 - Each year, the Commonwealth Fund selects an international cohort of Harkness Fellows in health care policy ...
Posted by Michael Wonder on 28 Aug 2019
Academics and researchers raise concerns with FDA’s plan for ‘integrated reviews’
28 August 2019 - More than 50 academics and researchers from Harvard, Yale, Johns Hopkins and other universities around the ...
Posted by Michael Wonder on 28 Aug 2019
Australian Public Assessment Reports for prescription medicines
28 August 2019 - TGA is reviewing the operation of transparency measures and are considering activities to increase transparency of ...
Posted by Michael Wonder on 28 Aug 2019
Patient Voice Aotearoa calls for PHARMAC reform
28 August 2019 - Patient Voice Aotearoa has launched a petition calling for the Minister of Health to initiate an ...